A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers.
Diabetic neuropathic foot ulcers represent a serious health care burden to patients and to society. While the management of chronic diabetic foot ulcers has improved in recent years, it remains a frustrating problem for a variety of clinicians. This review examines the scientific underpinnings supporting the use of becaplermin (Regranex((R)); Ortho-McNeil Pharmaceutical, Raritan, NJ), or recombinant human platelet-derived growth factor (rhPDGF-BB), in diabetic forefoot wounds. An emphasis is placed upon proper medical and surgical care of diabetic foot wounds, as multiple studies have demonstrated that the success of this growth factor in accelerating healing is ultimately dependent on proper ulcer care. A focus on the cost-effectiveness of this form of therapy in the treatment of diabetic foot ulcers is also outlined.
Fang
Robert C
RC
Division of Plastic and Reconstructive Surgery and Wound Healing Research Laboratory, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Galiano
Robert D
RD
Plast Reconstr Surg. 2002 Sep 15;110(4):1047-54; discussion 1055-7
12198416
Surg Clin North Am. 2003 Jun;83(3):531-45, vi
12822724
J Am Podiatr Med Assoc. 2005 Sep-Oct;95(5):451-4
16166462
Lancet. 2005 Nov 12;366(9498):1725-35
16291067
Br Med J (Clin Res Ed). 1986 May 17;292(6531):1295-8
2939920
J Clin Invest. 1991 Feb;87(2):694-703
1991853
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):193S-209S; discussion 210S-211S
16799388
Value Health. 2000 Nov-Dec;3 Suppl 1:39-46
16464208
Diabetes. 1998 Jun;47(6):859-66
9604860
Clin Sci (Lond). 1995 Nov;89(5):467-74
8549060
Diabetologia. 1994 Feb;37(2):141-4
8163047
J Clin Invest. 1995 Sep;96(3):1395-403
7544803
Biochem Biophys Res Commun. 2002 Aug 9;296(1):93-101
12147232
Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207-10
4208546
Orthopedics. 1992 Sep;15(9):1033-6; discussion 1036-7
1437862
Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S84-92
11054895
Diabetes Care. 1998 May;21(5):822-7
9589248
JAMA. 1997 May 21;277(19):1552-7
9153371
Med Decis Making. 1993 Oct-Dec;13(4):322-38
8246705
Lancet. 2005 Nov 12;366(9498):1736-43
16291068
Br J Surg. 2003 Feb;90(2):133-46
12555288
Dermatol Surg. 2001 Apr;27(4):347-51
11298704
Am J Surg. 2005 Aug;190(2):295-9
16023449
Wound Repair Regen. 1999 Sep-Oct;7(5):335-46
10564562
Ostomy Wound Manage. 2003 Nov;49(11):76-84
14652415
Diabetes Care. 2006 Jun;29(6):1263-8
16732006
N Engl J Med. 2004 Jul 1;351(1):48-55
15229307
J Vasc Surg. 1995 Jan;21(1):71-8; discussion 79-81
7823364
Science. 1966 Jan 14;151(3707):209-10
5907911
Ann Vasc Surg. 2005 Nov;19(6):805-11
16205848
Am J Surg. 1993 Jul;166(1):74-81
8392302
J Foot Ankle Surg. 2006 Sep-Oct;45(5 Suppl):S1-66
17280936
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):248S-253S
16799393
J Cell Biochem. 1991 Apr;45(4):319-26
2045423
Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):14-25
17179926
Wound Repair Regen. 2006 Nov-Dec;14(6):680-92
17199833
Arch Surg. 1994 Feb;129(2):213-9
8304833
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11555-8
1763069
Neurology. 2006 Jun 27;66(12):1805-8
16801641
N Engl J Med. 1984 Dec 20;311(25):1615-9
6390204
JAMA. 1997 Jun 11;277(22):1802-6
9178794
J Bone Joint Surg Am. 2003 Aug;85(8):1436-45
12925622
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):35S-41S
16799373
J Bone Joint Surg Am. 1976 Jan;58(1):42-6
1249111
Diabet Med. 1996 Feb;13(2):160-4
8641122
Science. 1996 May 3;272(5262):728-31
8614835
J Exp Med. 1988 Mar 1;167(3):974-87
3280728
Am J Surg. 1998 Aug;176(2A Suppl):80S-82S
9777977
Diabetes. 2005 Jun;54(6):1615-25
15919781
Med Res Rev. 2003 Mar;23(2):117-45
12500286
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):143S-149S; discussion 150S-151S
16799381
J Burn Care Rehabil. 2005 Jul-Aug;26(4):306-19
16006837
Am J Pathol. 1990 Jun;136(6):1235-46
2356856